143 related articles for article (PubMed ID: 17627483)
1. Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer's disease.
De Felice FG; Wasilewska-Sampaio AP; Barbosa AC; Gomes FC; Klein WL; Ferreira ST
Curr Alzheimer Res; 2007 Jul; 4(3):263-71. PubMed ID: 17627483
[TBL] [Abstract][Full Text] [Related]
2. Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound.
Wasilewska-Sampaio AP; Silveira MS; Holub O; Goecking R; Gomes FC; Neto VM; Linden R; Ferreira ST; De Felice FG
FASEB J; 2005 Oct; 19(12):1627-36. PubMed ID: 16195371
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease.
Amidfar M; de Oliveira J; Kucharska E; Budni J; Kim YK
Life Sci; 2020 Sep; 257():118020. PubMed ID: 32603820
[TBL] [Abstract][Full Text] [Related]
5. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
6. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
7. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
8. CREB: A Multifaceted Target for Alzheimer's Disease.
Sharma VK; Singh TG
Curr Alzheimer Res; 2020; 17(14):1280-1293. PubMed ID: 33602089
[TBL] [Abstract][Full Text] [Related]
9. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element binding protein.
Chong YH; Shin YJ; Suh YH
Mol Pharmacol; 2003 Mar; 63(3):690-8. PubMed ID: 12606779
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
Puzzo D; Vitolo O; Trinchese F; Jacob JP; Palmeri A; Arancio O
J Neurosci; 2005 Jul; 25(29):6887-97. PubMed ID: 16033898
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen and lipoic acid conjugate neuroprotective activity is mediated by Ngb/Akt intracellular signaling pathway in Alzheimer's disease rat model.
Zara S; De Colli M; Rapino M; Pacella S; Nasuti C; Sozio P; Di Stefano A; Cataldi A
Gerontology; 2013; 59(3):250-60. PubMed ID: 23428737
[TBL] [Abstract][Full Text] [Related]
14. Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.
Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Hernandez C; Barrett AD; Dineley K; Kayed R
J Neurosci; 2015 Mar; 35(12):4857-68. PubMed ID: 25810517
[TBL] [Abstract][Full Text] [Related]
15. A novel diol-derivative of chalcone produced by bioconversion, 3-(2,3-dihydroxyphenyl)-1-phenylpropan-1-one, activates PKA/MEK/ERK signaling and antagonizes Abeta-inhibition of the cascade in cultured rat CNS neurons.
Al Rahim M; Nakajima A; Misawa N; Shindo K; Adachi K; Shizuri Y; Ohizumi Y; Yamakuni T
Eur J Pharmacol; 2008 Dec; 600(1-3):10-7. PubMed ID: 18948095
[TBL] [Abstract][Full Text] [Related]
16. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells.
Garzon DJ; Fahnestock M
J Neurosci; 2007 Mar; 27(10):2628-35. PubMed ID: 17344400
[TBL] [Abstract][Full Text] [Related]
17. Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.
Choi M; Lee Y; Cho SH
Chin J Integr Med; 2018 May; 24(5):378-384. PubMed ID: 28578486
[TBL] [Abstract][Full Text] [Related]
18. cAMP, cGMP and Amyloid β: Three Ideal Partners for Memory Formation.
Ricciarelli R; Fedele E
Trends Neurosci; 2018 May; 41(5):255-266. PubMed ID: 29501262
[TBL] [Abstract][Full Text] [Related]
19. Copper chelators promote nonamyloidogenic processing of AβPP via MT
Wang Z; Zhang YH; Zhang W; Gao HL; Zhong ML; Huang TT; Guo RF; Liu NN; Li DD; Li Y; Wang ZY; Zhao P
J Pineal Res; 2018 Oct; 65(3):e12502. PubMed ID: 29710396
[TBL] [Abstract][Full Text] [Related]
20. CREB-regulated transcription coactivator 1-dependent transcription in Alzheimer's disease mice.
Saura CA
Neurodegener Dis; 2012; 10(1-4):250-2. PubMed ID: 22236576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
